This randomized , assessor-blind , controlled , clinical trial was conducted in an endemic area for CL caused by Leishmania major in Iran to assess the efficacy of administration of weekly intralesional meglumine antimoniate ( i.l.MA ) either alone or combined with application of a silver or a non-silver polyester dressing on their lesions for 6 weeks .
